ロード中...

O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions

Glioblastoma (GBM) is the most malignant type of primary brain tumor with a very poor prognosis. The actual standard protocol of treatment for GBM patients consists of radiotherapy and concomitant temozolomide (TMZ). However, the therapeutic efficacy of this treatment is limited due to tumor recurre...

詳細記述

保存先:
書誌詳細
主要な著者: Villalva, Claire, Cortes, Ulrich, Wager, Michel, Tourani, Jean-Marc, Rivet, Pierre, Marquant, Celine, Martin, Sebastien, Turhan, Ali G., Karayan-Tapon, Lucie
フォーマット: Artigo
言語:Inglês
出版事項: Molecular Diversity Preservation International (MDPI) 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397507/
https://ncbi.nlm.nih.gov/pubmed/22837675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms13066983
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!